financetom
Business
financetom
/
Business
/
Amazon, Microsoft back effort to curb Nvidia's exports to China, WSJ reports
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Amazon, Microsoft back effort to curb Nvidia's exports to China, WSJ reports
Nov 13, 2025 11:27 PM

Nov 13 (Reuters) - Amazon ( AMZN ) is joining Microsoft ( MSFT )

in backing legislation to further restrict chipmaker

Nvidia's ( NVDA ) ability to export chips to China, the Wall

Street Journal reported on Thursday, citing people familiar with

the matter.

The legislation, known as the GAIN AI Act, is also backed by

AI startup Anthropic, the report said.

Short for Guaranteeing Access and Innovation for National

Artificial Intelligence (GAIN), the Act was introduced as part

of the National Defense Authorization Act and stipulates that AI

chipmakers prioritize domestic orders for advanced processors

before supplying them to foreign customers.

Microsoft ( MSFT ) publicly came out in favor of the legislation,

while officials at Amazon's ( AMZN ) cloud unit have privately told

Senate staffers that they also support it, the report said.

Meta Platforms ( META ) and Alphabet's Google have

not taken a position on the Act, and neither has U.S. President

Donald Trump, the report added.

White House officials, including AI czar David Sacks, told

GAIN Act sponsor Senator Jim Banks that the policy's impact is

limited as the Commerce Department already regulates chip

exports, the report said.

Reuters could not immediately verify the report. Amazon ( AMZN )

declined to comment, while Microsoft ( MSFT ), Anthropic and the White

House did not immediately respond to Reuters' requests for

comment.

Nvidia ( NVDA ), the world's dominant chipmaker, has previously said

the GAIN AI Act stands to restrict global competition for

advanced chips, limiting computing power available to other

countries.

The touted legislation reflects Washington's attempt to

prioritize American needs amid fears that China would leverage

access to high-end AI capabilities to supercharge its military.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Gilead Sciences Q2 Adjusted Earnings Unchanged, Revenue Rises; Dividend Maintained
Gilead Sciences Q2 Adjusted Earnings Unchanged, Revenue Rises; Dividend Maintained
Aug 7, 2025
04:34 PM EDT, 08/07/2025 (MT Newswires) -- Gilead Sciences ( GILD ) reported fiscal Q2 adjusted earnings late Thursday of $2.01 per diluted share, unchanged from a year earlier. Analysts polled by FactSet expected $1.96. Revenue for the quarter ended June 30 was $7.08 billion, up from $6.95 billion a year earlier. Analysts surveyed by FactSet expected $6.98 billion. The...
Consumer products company Grove's Q2 revenue falls on reduced ads, net loss narrows on cost cuts
Consumer products company Grove's Q2 revenue falls on reduced ads, net loss narrows on cost cuts
Aug 7, 2025
Overview * Grove Q2 revenue falls 15.5% yr/yr to $44.0 mln, sequentially up 1.1% * Net loss improves to $3.6 mln from $10.1 mln last year * Adjusted EBITDA negative $0.9 mln, down from $1.1 mln last year Outlook * Grove expects Q3 revenue to improve, Q4 revenue to grow year-over-year * Full-year 2025 revenue expected to decline mid-single to...
Digital health firm OptimizeRx beats Q2 revenue view, raises FY guidance
Digital health firm OptimizeRx beats Q2 revenue view, raises FY guidance
Aug 7, 2025
Overview * OptimizeRx ( OPRX ) Q2 revenue grows 55% yr/yr, beating analyst expectations, per LSEG data * Adjusted EBITDA for Q2 beats consensus, reflecting strong operational performance * Co raises full-year 2025 guidance for revenue and adjusted EBITDA Outlook * Company raises 2025 revenue guidance to $104 mln-$108 mln * OptimizeRx ( OPRX ) expects 2025 adjusted EBITDA of...
Copyright 2023-2025 - www.financetom.com All Rights Reserved